Immuneering Corp. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Assertio Holdings, Inc.

Akebia Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

Enanta Pharmaceuticals, Inc.

Sutro Biopharma, Inc.

Ocular Therapeutix, Inc.

Generation Bio Co.

Praxis Precision Medicines, Inc.

Immuneering Corp.

Lifecore Biomedical, Inc.

AEON Biopharma, Inc.

Why is Immuneering Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Immuneering Corp. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Immuneering Corp.

184.44%

1.97

123.67%

S&P 500

16.12%

0.84

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-170.23%

EBIT to Interest (avg)

-46.97

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.85

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

61.85%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.41

EV to EBIT

-1.46

EV to EBITDA

-1.47

EV to Capital Employed

93.50

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-6418.14%

ROE (Latest)

-27.41%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

NET PROFIT(HY)

Higher at USD -29.4 MM

ROCE(HY)

Highest at -43.75%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -98.1 %

EPS(Q)

Highest at USD -0.38

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Immuneering Corp.

Net Profit

Higher at USD -29.4 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.38

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debt-Equity Ratio

Lowest at -98.1 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales